Case Study: A Lesson in CSA Compliance and Corresponding Responsibility

Pharmacists play a critical role in protecting patients and communities when dispensing controlled substances. When used appropriately, these medications can be life changing for patients with legitimate medical needs. However, when they are diverted or dispensed improperly, the consequences can be severe.

This responsibility is why the Controlled Substances Act (CSA) exists. The law establishes strict requirements for DEA registrants, including pharmacists, to ensure controlled substances are handled responsibly. Central to CSA compliance is the concept of corresponding responsibility, which requires pharmacists to verify that controlled substance prescriptions are issued for a legitimate medical purpose and within the usual course of professional practice. But what happens when a pharmacy fails to uphold its corresponding responsibility?

In February 2024, investigators from the Drug Enforcement Administration (DEA) concluded that a retail pharmacy in Laredo, Texas violated CSA compliance requirements related to recordkeeping and prescription legitimacy. According to the investigation, the pharmacy dispensed 173 controlled substance prescriptions that were improperly recorded and lacked documentation supporting a legitimate medical purpose.

As a result of these CSA violations, the pharmacy agreed to pay $750,000 in civil penalties to settle the allegations. A fine of this magnitude carries serious consequences. For many independent pharmacies, penalties of this size could threaten the long-term viability of the business. This case highlights the real risks that pharmacies face when CSA compliance processes break down, and corresponding responsibility is not properly exercised.

Under the Controlled Substances Act, pharmacists share corresponding responsibility with prescribing practitioners to ensure that controlled substances are dispensed for a legitimate medical purpose.

This means that pharmacists must use their professional training and judgment to evaluate prescriptions before dispensing them. Simply receiving a prescription from a licensed prescriber does not automatically make it valid. CSA compliance requires pharmacists to assess potential red flags and resolve concerns before dispensing controlled substances.

Common patient related red flags may include:

• Vaguely describing textbook symptoms while providing little medical history
• Refusing medical examinations or declining to share diagnostic test results
• Providing unusual explanations for suspicious behavior
• Paying entirely in cash or relying exclusively on Medicaid for controlled substances

Red flags can also appear in prescriber behavior, which may indicate potential diversion or inappropriate prescribing. Examples include:

• Seeing a large number of out of state patients
• Ignoring evidence of patient abuse or concerning toxicology reports
• Prescribing narcotic controlled substances as the primary or only treatment option
• Starting patients on unusually high doses instead of gradually adjusting treatment

Maintaining CSA compliance requires pharmacists to recognize and resolve these red flags before dispensing medications.

In the Laredo case, the DEA determined that the pharmacy failed to properly exercise corresponding responsibility. The investigation found that 173 controlled substance prescriptions were approved and dispensed without adequate verification of legitimate medical purpose.

Failing to evaluate suspicious prescriptions is more than a documentation issue. It represents a breakdown in the pharmacy’s CSA compliance program and can contribute to controlled substance diversion within the community.

Cases like this highlight the importance of building strong systems that support CSA compliance and corresponding responsibility in everyday pharmacy operations. One of the most effective ways to strengthen CSA compliance is through regular internal audits and inventory controls.

Accurate recordkeeping is a fundamental requirement under the Controlled Substances Act. Pharmacies should routinely review records related to:

• Controlled substances received from wholesalers
• Dispensed medications
• Damaged or destroyed inventory
• Expired medications

At the federal level, pharmacies are required to conduct a biennial inventory of their controlled substances every two years, although some states require more frequent reporting. Many compliance experts recommend performing internal audits more often to maintain stronger oversight.

Another useful method is back counting, which involves physically counting remaining inventory to verify that the physical quantity matches the quantity recorded in the pharmacy management system. This practice helps identify discrepancies quickly and reinforces strong CSA compliance habits.

Beyond recordkeeping, pharmacies must also focus on training and compliance. Corresponding responsibility requires staff members to feel confident identifying suspicious prescriptions and escalating concerns. Regular training sessions can help pharmacy teams recognize red flags, understand regulatory expectations, and respond appropriately when potential compliance issues arise.

Pharmacies should also stay current with guidance from the DEA and other regulatory organizations that provide training materials and educational resources related to opioid stewardship and controlled substance monitoring.

However, implementing these safeguards can be challenging. Independent pharmacies often operate under significant staffing and financial pressures. Pharmacists must balance patient care, prescription volume, insurance requirements, and administrative responsibilities. Without efficient systems in place, maintaining consistent CSA compliance can become difficult.

The real challenge is finding ways to embed compliance into daily workflows rather than adding more administrative tasks to an already demanding workload.

The Laredo case offers several important lessons for pharmacy owners and staff:

• First, CSA compliance must remain a daily priority. Even a small number of improperly evaluated prescriptions can trigger serious regulatory consequences.
• Second, corresponding responsibility is an active obligation, not a passive one. Pharmacists are expected to use professional judgment to identify suspicious activity and document how concerns were addressed before dispensing controlled substances.
• Third, compliance systems are only effective when pharmacy teams are committed to using them consistently. Policies, tools, and procedures can support CSA compliance, but they must be reinforced through training and leadership.

The consequences of neglecting corresponding responsibility can be severe. DEA investigations often involve extensive audits, legal expenses, and reputational damage. Financial penalties can reach hundreds of thousands of dollars, which can be devastating for independent pharmacies.

Maintaining strong CSA compliance practices helps pharmacies protect their patients, their communities, and their businesses.

For pharmacies committed to strengthening CSA compliance, technology can play a powerful role in simplifying compliance management.

C2 Keep was developed specifically to address the operational challenges that pharmacies face when managing controlled substance compliance. After experiencing these challenges firsthand as a pharmacy director, Roland Achenjang, founder and CEO of C2 Keep, created a platform designed to make CSA compliance more efficient and reliable.

By automating critical compliance tasks, C2 Keep helps pharmacies strengthen their CSA compliance programs without adding additional administrative burden to already busy teams. Today, more than 2,000 pharmacy professionals across the United States use C2 Keep to simplify controlled substance compliance and improve operational efficiency.

Schedule a demo to learn more.